Get's Al Shifa

Get's Al Shifa LIFE SAVING & ANTI CANCER GENERIC MEDICINE DISTRIBUTOR. [email protected]

https://wa.me/message/RG4ONZQ7ZFPCC1

Are you looking for a targeted therapy product for Advanced Kidney Cancer / RCC?💊 LUCIAXI® 5 mgAxitinib Tablets | 60 Tab...
21/09/2026

Are you looking for a targeted therapy product for Advanced Kidney Cancer / RCC?

💊 LUCIAXI® 5 mg
Axitinib Tablets | 60 Tablets | Rx Only
LuciAXI® 5 mg contains Axitinib, a targeted tyrosine-kinase inhibitor used in the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer.

🎯 MAIN THERAPEUTIC USE
Advanced Renal Cell Carcinoma (RCC)
Axitinib is used in appropriate advanced RCC treatment settings, including certain combination regimens and, depending on the indication, after previous systemic therapy.

💎 PRODUCT VALUE
✔️ Specialized oncology molecule
✔️ VEGFR-targeted therapy
✔️ Established RCC treatment category
✔️ Oral tablet formulation
✔️ 5 mg strength
✔️ 60-tablet pack

🌍 For Pharmaceutical Importers, Distributors, Wholesalers & Oncology Buyers
Looking to add Axitinib to your oncology portfolio?

📩 Contact us for product availability, quotation and B2B supply information.

Gets Al Shifa Is Best Option For.
Contact Us on WhatsApp: 01575-308158

:

06/09/2026


Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Rulicent 10 — ( ) 10 mg⚕️ Important Safety InformationPrescription-only medicine. Use strictly under the supervision of ...
03/09/2026

Rulicent 10 — ( ) 10 mg

⚕️ Important Safety Information
Prescription-only medicine. Use strictly under the supervision of a qualified physician.

Ruxolitinib may reduce platelet, hemoglobin, and white blood cell counts. Regular blood tests, including CBC, may be required.

It may increase the risk of serious infections. Seek medical attention for fever, persistent cough, or other signs of infection.

Do not stop treatment suddenly unless advised by your doctor, as symptoms may worsen or return.
Tell your doctor about any existing liver or kidney problems, infections, or other medicines you are taking.
The appropriate dose and treatment duration depend on the patient's condition and laboratory results.

💊 Main Uses:
Ruxolitinib is primarily used under specialist medical supervision for:
1. Myelofibrosis (MF)
Helps control symptoms and disease-related complications in patients with intermediate- or high-risk myelofibrosis.
2. Polycythemia Vera (PV)
Used in certain adults who have an inadequate response to or cannot tolerate hydroxyurea.
3. Graft-versus-Host Disease (GVHD)
Used for certain patients with steroid-refractory acute or chronic GVHD.

⚠️ Important: Ruxolitinib is a specialized medicine and is not suitable for self-medication. A hematologist/qualified physician should determine whether it is appropriate for an individual patient.

✅ Order From Get's Al Shifa .
🌍 website: dcenbd.com
📞 WhatsApp Us: +8801575308158

02/09/2026

Upajak ( ) 15 mg.

Rheumatoid Arthritis (RA): Helps reduce joint inflammation, pain, stiffness, and swelling.
Psoriatic Arthritis (PsA): Helps control inflammation and improve joint symptoms.
Atopic Dermatitis (Eczema): Used for moderate-to-severe atopic dermatitis in appropriate patients.
Ulcerative Colitis (UC): Helps induce and maintain remission in eligible patients.
Crohn’s Disease: Used for moderate-to-severe Crohn’s disease in appropriate patients.
Mechanism: A selective JAK1 inhibitor that modulates inflammatory signaling involved in these conditions.

Pharmaceutical Supply
B2B Enquiries, Worldwide Buyers & Distributors Welcome to Al Shifa.

For Order Form us WhatsApp us: +8801575308158

Visit website: dcenbd.com

01/09/2026

NIRANIB ( ) 100 mg Capsules

A PARP Inhibitor for Maintenance Therapy in Ovarian Cancer

Key Uses & Clinical Role:
Used as maintenance therapy for eligible adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

May be used following a complete or partial response to platinum-based chemotherapy, according to the approved indication.

In the first-line setting, current U.S. labeling specifies HRD-positive disease, including qualifying BRCA mutations and/or genomic instability.

Also indicated for certain patients with recurrent germline BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer following response to platinum-based chemotherapy.

Niraparib works by inhibiting PARP-1 and PARP-2, enzymes involved in DNA repair, helping promote DNA damage in susceptible cancer cells.

Professional Note: Prescription oncology medicine. Patient selection, dosing, genetic/HRD testing and monitoring should be determined by a qualified oncology specialist.



Available From Al Shifa.
visit My Website: dcenbd.com
WhatsApp: +8801575308158

31/08/2026

Gets Al Shifa

31/08/2026

💊 APESIB® — ALPELISIB TABLETS

ADVANCED TARGETED ONCOLOGY THERAPY.

Precision. Targeted Action. Oncology Care.

APESIB® contains Alpelisib, a selective PI3Kα inhibitor developed for targeted treatment of PIK3CA-mutated, HR-positive / HER2-negative advanced or metastatic breast cancer.

🔬 HOW IT WORKS:
Alpelisib targets the PI3Kα signaling pathway, helping suppress abnormal cancer-cell signaling and limiting tumor-cell growth and proliferation.

⭐ KEY CLINICAL APPLICATION
• PIK3CA-mutated advanced/metastatic breast cancer
• HR-positive / HER2-negative disease
• Used in combination with Fulvestrant
• Targeted oncology treatment following progression on endocrine-based therapy

🌍 GLOBAL PHARMACEUTICAL SUPPLY
APESIB® | Alpelisib Tablets
✔ Oncology Product
✔ Prescription Medicine
✔ Suitable for pharmaceutical importers, distributors & healthcare supply networks
✔ Availability subject to destination-country regulatory requirements.

📩 For serious B2B inquiries:
Product Availability • Specifications • Documentation • Commercial Offers • Export Supply.

Available From Gets Al Shifa.
WhatsApp: +8801575308158

🔹Uses:Pembrolizumab is an anti-PD-1 immunotherapy used for the treatment of various cancers. It helps activate the body'...
30/08/2026

🔹Uses:
Pembrolizumab is an anti-PD-1 immunotherapy used for the treatment of various cancers. It helps activate the body's immune system to recognize and fight cancer cells.
🔹 Used in:
• Lung Cancer
• Melanoma
• Head & Neck Cancer
• Urothelial Cancer
• Hodgkin Lymphoma
• Other approved cancer indications
💉 IV Infusion | 100mg/4mL | Single Dose Vial
❄️ Storage: 2°C–8°C | Do Not Freeze

Available From Gets Al Shifa.
For Order Whatsapp us: +8801575308158

30/08/2026

dcenbd.com
WhatsApp: +8801575308158

💊 IVOSENIB 250 mg — IvosidenibActive Ingredient: Ivosidenib 250 mgDrug class: Targeted anticancer therapy / IDH1 inhibit...
27/08/2026

💊 IVOSENIB 250 mg — Ivosidenib
Active Ingredient: Ivosidenib 250 mg
Drug class: Targeted anticancer therapy / IDH1 inhibitor
Pack shown: 60 film-coated tablets.

🔬 How it works:
Ivosidenib is a selective inhibitor of mutant IDH1 (isocitrate dehydrogenase-1). Certain IDH1 mutations cause abnormal production of the metabolite 2-hydroxyglutarate, which can interfere with normal cell differentiation. By inhibiting mutant IDH1, ivosidenib helps reduce this abnormal signaling and can promote differentiation of cancer cells.

🎯 Main approved uses:
Ivosidenib is used for specific IDH1-mutated cancers, including:
Acute Myeloid Leukemia (AML) — certain newly diagnosed patients and adults with relapsed/refractory AML.
Cholangiocarcinoma (bile-duct cancer) — previously treated, locally advanced or metastatic disease with an IDH1 mutation.
Myelodysplastic Syndromes (MDS) — relapsed/refractory adult patients with a susceptible IDH1 mutation.

⚠️ Important: Treatment selection requires confirmation of an appropriate IDH1 mutation using an approved diagnostic test. Ivosidenib is a prescription oncology medicine and should be used under specialist supervision. It also carries an important warning for differentiation syndrome, which can be serious or fatal if untreated.

For Order From Al Shifa Drug.
WhatsApp us: +8801575308158

Address

92 Al Khalif Trust Tower
Dhaka

Telephone

+8801575308158

Website

, ,

Alerts

Be the first to know and let us send you an email when Get's Al Shifa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Get's Al Shifa:

Shortcuts

Share